About HeaDS
HeaDS is a Healthcare company based in Athens (Greece) founded in 2010, and was acquired by Veeda Clinical Research in March 2024. Pharmacovigilance, regulatory affairs, and quality assurance services are provided. The company has 1,618 employees. Its Indian entity Veeda Clinical Research Limited reported revenue of ₹284 Cr. HeaDS offers products and services including Preclinical Services, Clinical Trials, Bioanalytical Services, and Real World Evidence. Its focus areas include Biopharma Outsourcing, Consulting and Diversified.
Company details
HeaDS was founded in 2010 and is based in Athens, Greece. Services in pharmacovigilance, regulatory affairs, and quality assurance are offered to clients in the pharmaceutical and healthcare sectors. Operations are centered on compliance support, risk management, and documentation processes. The company serves international markets through its domain heads-research.com, with a focus on regulatory submissions and safety monitoring. Expertise is applied to ensure adherence to global standards.
- Headquarters Athens, Greece
- Employees 1,618
- Stage Acquired
- SectorsHealthcare
- Website heads-research.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Veeda Clinical Research (Mar 2024)
- Legal Name Veeda Clinical Research Limited
- Date of Incorporation 23 Apr, 2004
- Jurisdiction Ahmedabad, Gujarat, India
- Indian entity revenue₹284 Cr
FY 2025 · +52% YoY
- Indian entity net loss-₹66.81 Cr
FY 2025 · -11% margin
- Indian entity EBITDA₹136 Cr
FY 2025 · 22% margin
- Investors
- Employee Count1,618
- Acquired byVeeda Clinical Research
(Mar 2024)
Associated legal entities of HeaDS
HeaDS operates through Veeda Clinical Research Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Veeda Clinical Research Limited CIN U73100GJ2004PLC044023 | Active | 23 Apr 2004 | Ahmedabad, Gujarat | ₹284 Cr | 902 | 18 | View details |
Products & Services of HeaDS
HeaDS offers a comprehensive portfolio of products and services, including Preclinical Services, Clinical Trials, Bioanalytical Services, and Real World Evidence.
Supports drug discovery and IND submission processes.
Conducts phases I-IV trials for various therapeutics.
Handles method development and sample analysis for drugs.
Uses real-world data to improve trial recruitment and outcomes.
Apps and channels of HeaDS
its YouTube channel Veeda Lifesciences has 391 subscribers and 30 videos.
Videos from HeaDS
The most watched videos on HeaDS's YouTube channel, Veeda Lifesciences (391 subscribers). Click a video to play it here.
More on Veeda Lifesciences.
Investors in HeaDS
HeaDS has secured backing from 1 investor. Prominent investors backing the company include Veeda Clinical Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | veedacr.com | Ahmedabad, India |
Investor details for HeaDS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Veeda Clinical Research Limited (HeaDS)
Veeda Clinical Research Limited is the primary company behind HeaDS. The board of Veeda Clinical Research Limited currently have 15 directors; the longest-serving is Vivek Chhachhi, appointed in 2018. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vivek Chhachhi DIN 00496620 | Nominee Director | 21 Nov 2018 | 7 yrs 11 mo | Veeda Clinical Research Limited |
| Kiran Vithaldas Marthak DIN 00298288 | Director | 17 Aug 2020 | 6 yrs 2 mo | Veeda Clinical Research Limited |
| Nirmal Atmaram Bhatia DIN 09068966 | CFO | 22 Jun 2021 | 5 yrs 4 mo | Veeda Clinical Research Limited |
| Nitin Jagannath Deshmukh DIN 00060743 | Director | 01 Jul 2021 | 5 yrs 4 mo | Veeda Clinical Research Limited |
| Jeanne Taylor Hecht DIN 09209900 | Director | 01 Jul 2021 | 5 yrs 4 mo | Veeda Clinical Research Limited |
| Rakesh Bhartia DIN 00877865 | Director | 01 Jul 2021 | 5 yrs 4 mo | Veeda Clinical Research Limited |
| Shankarappa Nagaraja Vinaya Babu DIN 01373832 | Director | 16 Jul 2021 | 5 yrs 4 mo | Veeda Clinical Research Limited |
| Mahesh Kumar Kantilal Bhalgat DIN 07253670 | CEO | 03 Jan 2024 | 2 yrs 10 mo | Veeda Clinical Research Limited |
| Tanushree Akshay Agarwal DIN 07160692 | Nominee Director | 09 May 2024 | 2 yrs 6 mo | Veeda Clinical Research Limited |
| Ioannis Orfanidis DIN 10726960 | Nominee Director | 12 Aug 2024 | 2 yrs 3 mo | Veeda Clinical Research Limited |
| David Paul Kenny DIN 10867455 | Director | 11 Dec 2024 | 1 yr 11 mo | Veeda Clinical Research Limited |
| Georgios Kouvatseas DIN 11019257 | Nominee Director | 26 Mar 2025 | 1 yr 7 mo | Veeda Clinical Research Limited |
| Vinayak Prabhakar Shenvi DIN 00694217 | Nominee Director | 13 Aug 2025 | 1 yr 3 mo | Veeda Clinical Research Limited |
| Binoy Hasmukh Gardi DIN 00298262 | Managing Director | 19 Jan 2026 | 9 mo | Veeda Clinical Research Limited |
| Apurva Bhupendra Shah DIN 00378260 | Director | 30 Mar 2026 | 7 mo | Veeda Clinical Research Limited |
People of HeaDS
15 people are tracked at HeaDS (2 in leadership, 13 in team); the tracked headcount is 1,618.
| Name | Role | Group |
|---|---|---|
Chiranjeeb Das | Head Of Clinical Data Management Processes | Leadership |
Rita Filippou | Vp, Regulatory And Clinical Affairs | Leadership |
Pallavi Jha | Associate Manager Clinical Data Management | Team |
George Pramantiotis | Data Engineer | Clinical Engineer | Team |
Marieta Riga | Senior Clinical Operations Manager | Team |
Alexandra Alvarez | Clinical Research Associate | Team |
Argiris Papaioannou | Clinical Informatics | Team |
Athina Goudopoulou | Pharmacovigilance Senior Manager | Team |
Angeliki Mougiou | Clinical Data Manager I | Team |
Ilias Starogiannis | Quality Assurance Manager | Team |
Matteo Razzetti | Clinical Data Manager | Team |
Olga Konstantinidou | Assoc. Regulatory Submissions Manager | Team |
Mixalis Karavas | SQL Developer / Data Engineer | Team |
Luis Alfonso Bolívar P. | Clinical Research Associate | Team |
Anastassiya Savin | Clinical Research Associate | Team |
Complete people profiles for HeaDS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of HeaDS
Figures of Veeda Clinical Research Limited, the primary company behind HeaDS, for FY 2025. Revenue was ₹284 Cr (+52% year on year). Net loss was -₹66.81 Cr (-11% margin). EBITDA was ₹136 Cr (22% margin). Revenue has grown at a compounded annual rate of +28% over three years and 0% over five years.
- ₹284 CrRevenue · FY 2025 · +52% YoY
- -₹66.81 CrNet loss · -11% margin
- ₹136 CrEBITDA · 22% margin
- ₹13.97 CrPaid-up capital
- 902Employees (provident fund records)
- +28%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Veeda Clinical Research Limited are on its company page.
Detailed financial statements for HeaDS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of HeaDS
2 dated milestones of HeaDS across 14 years, from founding to its latest funding, stage changes and deals.
- Founded HeaDS is founded.
- Exit Acquired by Veeda Clinical Research.
Web traffic of HeaDS
The website of HeaDS (heads-research.com) receives about 1K visits a month.
- Monthly visits1K
▲ 207% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Heads
Complete news archive for HeaDS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HeaDS
HeaDS was founded in 2010.
HeaDS is headquartered in Athens, Greece.
HeaDS has 1,618 employees.
The primary company behind HeaDS, Veeda Clinical Research Limited, reported revenue of ₹284 Cr for FY 2025, up 52% year on year.
HeaDS was founded in 2010 and is based in Athens, Greece. Services in pharmacovigilance, regulatory affairs, and quality assurance are offered to clients in the pharmaceutical and healthcare sectors. Operations are centered on compliance support, risk management, and documentation processes. The company serves international markets through its domain heads-research.com, with a focus on regulatory submissions and safety monitoring. Expertise is applied to ensure adherence to global standards.
HeaDS offers Preclinical Services, Clinical Trials, Bioanalytical Services, and Real World Evidence.
HeaDS has 1 investor. Key investors include Veeda Clinical Research.
HeaDS operates through Veeda Clinical Research Limited.
Yes. HeaDS was acquired by Veeda Clinical Research in March 2024.
The legal entities of HeaDS currently have 15 directors, including Nirmal Atmaram Bhatia, Apurva Bhupendra Shah, Nitin Jagannath Deshmukh and others.